about
Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implicationsOxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosisArtery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.Generation and biological activities of oxidized phospholipidsThe effect of oxidized phospholipids on phenotypic polarization and function of macrophages.Lymphocytes and the adventitial immune response in atherosclerosis.B cell subsets in atherosclerosis.Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profilingClinical significance of the humoral immune response to modified LDL.Inflammation in atherosclerosis: from pathophysiology to practiceAnti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological eventInflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome.Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems.In situ IgM production and clonal expansion of B-1 cells in peritoneal cavity promote elimination of C. albicans infection in IgH transgenic mice with VH derived from a natural antibody.Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.Natural and disease-specific autoantibodies in chronic obstructive pulmonary diseaseSterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response.Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosusHeart disease is common in humans and chimpanzees, but is caused by different pathological processes.Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques.Immune response to lipoproteins in atherosclerosis.Emerging applications for zebrafish as a model organism to study oxidative mechanisms and their roles in inflammation and vascular accumulation of oxidized lipidsImmunomodulation of atherosclerosis with a vaccine.Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessmentHumoral innate immune response and disease.Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age.Atherogenesis and the humoral immune response to modified lipoproteinsOxidation-specific epitopes are important targets of innate immunity.2015 Russell Ross Memorial Lecture in Vascular Biology: Protective Autoimmunity in AtherosclerosisOxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humansAntigen-induced immunomodulation in the pathogenesis of atherosclerosis.Immune and inflammatory mechanisms of atherosclerosis (*)The role of adaptive T cell immunity in atherosclerosis.The role of innate immunity in atherogenesis.Athletes with higher VO2max present reduced oxLDL after a marathon raceEvidence for a novel human-specific xeno-auto-antibody response against vascular endothelium.Toll-Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells.
P2860
Q26740418-431A1F65-2228-48E3-8B8E-B743E24BD041Q26822962-AE290FF3-587A-4BBA-B81E-F481D20712FAQ28072367-0B0C5EA6-B97B-4151-BF5B-BAF15FAC930BQ28389691-A446A599-1EF2-45EE-AD95-2D6D8983005FQ30268532-514E3686-2736-4B21-9A45-DCFE4CD6954DQ30421884-B8FEA2E5-45CE-4958-BB25-6BD6854DCD72Q30423324-A4EBD6EF-0F41-4BFE-AD9E-912E1D098B66Q33355010-B5E6BBEB-7D22-4DEB-B951-A52F2DEBF51EQ33598770-B91A4DE7-6D07-47F2-9866-222EE91B180DQ33709505-2D18B834-FBB4-47A2-B038-8583413ACD93Q33773528-01C4A28C-92BB-4F11-8AF2-80D320E2BF73Q33906276-44968F43-9FAD-48FA-81C6-98827D741457Q34287672-8821C50A-B1F5-4E3B-BB65-33A804DDDF9DQ34427494-33EFCBD4-3F3C-4A60-9EB6-769356AACFFFQ34556407-E3DB6E31-BE2C-48B3-820E-094963A0345DQ34658590-529DE13B-AFA3-4D40-BE85-2C546E05CCE3Q34805613-20E51827-C961-42A0-8642-C36DF759FDBFQ35198950-FB4E6773-F598-4605-A13C-D5304ACEC116Q35549073-2A5710FD-A1A3-40A2-B157-0D6A431367AAQ35567857-F69474F8-D028-42D2-A9DC-23CEF277BEFCQ35960796-1FB596F6-1CE8-4E04-874F-3B3E9DA977C3Q36184299-EA25860E-E665-4952-953D-1E838DABE0CCQ36203882-A376A9AC-C66A-4D48-9D5F-568698E54D02Q36252515-6B3A2E28-6EC9-4227-97FB-0B455CB8747EQ36321769-F91E22A8-1827-4A96-96C9-1BDD73012312Q36328740-5863E3B1-2054-4556-B3AA-6017880B13ACQ36623129-EFF1E654-D716-4CC0-83B1-A309B44D1BBEQ36860384-947FF821-B2A1-4AAB-AFEC-0074C5BEAF55Q36921429-0E442A2E-B678-4F73-9862-9C820C90D9EFQ37021490-4023F5E5-06D2-4D72-86C5-0A3BC2CBCAF3Q37138021-33FB0CF7-25A7-46E4-9CF2-A17CDF710323Q37146276-878D114C-12A0-4303-B12A-DD26A735BC73Q37170775-4ED9C413-791D-4ABC-B72B-9D46D5DB4FBCQ37190468-A311EBAF-8639-4DB0-8870-9999D00836B4Q37325024-4A909BF0-03FD-4412-B6AD-3A16E5D19075Q37339539-0B03B599-12C6-4A5A-BCAD-300CAB6A7A8FQ37357462-554E78AB-EDAE-401C-8394-87FE72779EFDQ37425498-BBCCDA34-08AB-4CD4-8817-B168A65E31BFQ37472019-C1174C1B-FB97-4D47-97E5-446EA95055B2Q37556177-5E95D53A-97DE-4046-B56E-D6413607BC6F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The role of natural antibodies in atherogenesis.
@ast
The role of natural antibodies in atherogenesis.
@en
type
label
The role of natural antibodies in atherogenesis.
@ast
The role of natural antibodies in atherogenesis.
@en
prefLabel
The role of natural antibodies in atherogenesis.
@ast
The role of natural antibodies in atherogenesis.
@en
P2093
P1476
The role of natural antibodies in atherogenesis.
@en
P2093
Agnès Boullier
Christoph J Binder
Douglas A Woelkers
Karsten Hartvigsen
Maripat Corr
Mi-Kyung Chang
Peter X Shaw
Sohvi Hörkkö
Yury I Miller
P304
P356
10.1194/JLR.R500005-JLR200
P577
2005-05-16T00:00:00Z